Who we are

PharmaLex APAC acts as a liaison to set up cooperations and extend exchange with the PharmaLex Group and our local APAC global partner.

  • Through the liaison office PharmaLex APAC covers all services required by health agencies worldwide and partners with customers from APAC to provide solutions for their international needs.
  • We help customers in APAC to access mature markets like the US and Europe.
  • Our APAC partner is able to understand local nuances of the regulatory framework for international clients interested in the APAC market.
  • Our goal is to offer enhanced regulatory support to customers throughout APAC’s pharma market.

Local Contact

  • Rashim Sharma
    Assistant Director – Business Development & Marketing PharmaLex APAC
Download Terms and Conditions

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • Worked with us and our contractors to help us achieve our tight targets, operate with our systems and procedures and are considered invaluable part of our team

    US based large development group
    VP Regulatory / Quality

  • We needed a partner to help us obtain device approval. PharmaLex have not only helped us achieve this but are now providing on-going post-marketing surveillance support. We would highly recommend them to anyone who needs specialist expertise.

    Med Device company, US
    Senior Regulatory Affairs Director

  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy

  • During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

    Large Pharma, Germany
    VP Regulatory Affairs

Related News